Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2024 Nov 2:2024.11.01.621145. [Version 1] doi: 10.1101/2024.11.01.621145

Collagen binding adhesin restricts Staphylococcus aureus skin infection

Mohini Bhattacharya 1, Brady L Spencer 1,+, Jakub M Kwiecinski 2, Magdalena Podkowik 5,6, Gregory Putzel 4,6, Alejandro Pironti 4,6, Bo Shopsin 4,5,6, Kelly S Doran 1, Alexander R Horswill 1,3,7,*
PMCID: PMC11565922  PMID: 39554114

Summary

Staphylococcus aureus causes approximately 80% of skin and soft tissue infections (SSTIs). Collagen is the most abundant human extracellular matrix protein with critical roles in wound healing, and S. aureus encodes a collagen binding adhesin (Cna). The role of this protein during skin infections is unknown. Here we report that inability to bind collagen results in worsened pathology of intradermal Δcna S. aureus infection. WT/Cna+ S. aureus showed reduced infection severity, aggregate formation, and significantly improved clearance of bacteria. Cna binds to the collagen-like domain of serum C1q protein to reduce its opsonophagocytic functions. We demonstrate that infection of C1qKO mice with WT bacteria show results similar to the Δcna group. Conversely, inability to bind collagen resulted in an amplified inflammatory response caused in part by macrophage and neutrophil small molecule mediators released at the infection site (MMP-9, MMP-12, LTB4), resulting in increased immune cell infiltration and death.

Keywords: Collagen, skin, MRSA, C1q, inflammation

Introduction

Collagen is the most abundant component of the human extracellular matrix, forming 30% of the protein dry weight in the human body1. With an essential role in wound healing, collagen is made up of 3 polypeptide alpha chains with characteristic Gly-X-X’ motifs that assemble to form a right-handed helical structure commonly identified as the ‘collagen like domain’2,3. Staphylococcus aureus is the most common cause of skin and soft tissue infections (SSTIs) such as abscesses, carbuncles and furuncles4,5. The treatment of these infections is often complicated by the acquisition of antibiotic resistance, the most common of which is the development of methicillin resistant S. aureus (MRSA)5,6. USA300 is a particularly problematic MRSA that has been implicated in a large percentage of SSTIs in the Unites States, for more than a decade6,7. The success of S. aureus as a pathogen is in part because it is particularly adept at expressing numerous toxins that target host cells or evade immune responses8,9. Once such evasion tactic is the expression of surface adhesins that bind host extracellular matrix components10. Among these proteins is the collagen binding adhesin (Cna) expressed by a subset of strains. USA400 strain MW2, is another epidemic MRSA with steadily reducing incidences in the United States, Europe and Canada over the past 15 years1114. MW2 expresses Cna. As a typical sortase anchored protein, Cna is attached to the cell wall via a C-terminal LPXTG motif15. The N-terminal A domain is characterized as being required for binding to collagen in the S. aureus strain Phillips16. Multiple mouse models of intravenous injection demonstrate a role for Cna in the virulence of septic arthritis, keratitis and osteomyelitis caused by S. aureus, some with conflicting results1721. There are currently no documented roles for Cna in the pathogenesis of S. aureus skin infection.

The N-terminal A domain of Cna is also reported to bind the N-terminal collagen-like tail of serum protein C1q to prevent the classical pathway of complement mediated killing in strain Phillips22. While the C-terminal globular head of C1q binds either directly to bacteria via pathogen associated molecular patterns (PAMPs), or to immunoglobulins on the bacterial surface, the N-terminal collagen like domain is recognized by innate immune cells23. Neutrophils and macrophages are key effectors in the phagocytic removal of opsonized bacteria. Following recognition of C1q bound to bacteria, a series of host proteolytic events results in the formation of C3b, via the C3 convertase (C4b2a). Deposition of C3b on the surface results in bacterial uptake by neutrophils and macrophages which utilize toxic, antibacterial effectors to eliminate bacterial populations from the infection site24. Alternatively, immune cells that are unable to phagocytose bacteria will use degranulation, reactive oxygen burst and extracellular trap formation as mechanisms to release antimicrobial compounds that kill bacteria25,26. Unlike phagocytosis, these processes can result in a higher degree of inflammation. Matrix metalloproteases (MMPs) are an important subclass of soluble mediators, with Zn2+ and Ca2+ dependent endopeptidase activities required for tissue remodeling. MMP-9 is released largely by neutrophils during degranulation but also by monocytes and macrophages. In addition to its collagenase activity, MMP-9 enhances TNF-α and IL-1β signaling and binds to CXCL8, cleaving the cytokine to increase its chemotactic potency 10-fold27. Additionally, the collagenase activity of MMP-9 results in the formation of the inflammatory fragment, Pro-Gly-Pro which is also a potent neutrophil chemotactic factor, thereby augmenting the inflammatory response to infection. Multiple reports demonstrate that MMP-9 is a significant contributing factor for pathogen control and removal2830. The elastase MMP-12 is released primarily from macrophages and is required for macrophage infiltration into infection sites. The hemopexin domain of this protein is reported to have bactericidal activity specifically against S. aureus 31,32. The coordinated activity of neutrophil and macrophage derived MMPs cause the activation of leukotriene hydrolases such as LTAH4 which results in the release of leukotriene B4, an additional pro-inflammatory mediator33. The contribution of these MMPs at the infection site is therefore significant to the inflammatory cascade induced by infection.

Our studies demonstrate that Cna+ S. aureus causes skin infections with significantly reduced bacterial loads accompanied by less inflammation, when compared with those caused by S. aureus unable to express Cna. We show that binding to collagen and the collagen-like motif of C1q reduces bacterial spread and the inflammatory response to infection respectively. The two major populations of immune cells affected by Cna-expressing bacteria are neutrophils and macrophages, both of which instigate a cycle of inflammation at the infection site that is propagated by increased release of matrix metalloproteases. Altogether this is the first report for the role of Cna in S. aureus skin infection and highlights the significance of collagen to infection outcomes.

Results

Expression of collagen binding adhesin (Cna) is sufficient to limit S. aureus abscess formation and bacterial burden.

To evaluate the role of collagen binding adhesin in the outcome of S. aureus-associated skin infections, we utilized the clinical, MRSA USA400 MW2 strain of S. aureus that expresses Cna (hereafter WT), an isogenic mutant unable to synthesize Cna, (Δcna) and a corresponding Δcna strain where cna is ectopically expressed from a plasmid Δcna:pCna (hereafter comp cna). In vitro adhesion assays demonstrate that expression of Cna by WT MW2 is sufficient for bacterial binding to collagen, a phenotype that is abrogated in the Δcna isogenic mutant (Figure S1A). Collagen binding was restored in comp cna bacteria and cna was required to induce binding when heterologously expressed in the non-pathogenic Staphylococcus carnosus (Figure S1B).

We therefore utilized this MRSA strain in an established model of intradermal abscess infection and monitored abscess size and weight loss in female, age matched BALB/c mice over a 7-day period34,35. At the end of the experiment, lesions were excised and colony forming units per gram (CFU/g) of homogenized tissue were measured (Figure 1A). WT and comp cna infected animals demonstrated weight loss comparable to the negative control group injected with saline, while Δcna infected mice lost ~10–20% of their initial weight (Figure 1B). Mice infected with the Δcna mutant also formed discernably larger abscesses when compared with WT and comp cna infected groups (Figure 1C, D). Larger lesions were accompanied by higher levels of recovered CFU/g (~1.5 log) of tissue in these mice, indicating exacerbated skin abscess infection in the absence of Cna (Figure 1E).

Figure 1. Collagen binding adhesin reduces severity of S. aureus skin infection.

Figure 1.

Method used for intradermal S. aureus infection and abscess formation (A). Weight loss measured over the 7-day infection period in mice (n=10 per bacterial strain) infected with WT MW2, isogenic Δcna or comp cna bacteria and calculated as a percentage of values at day 1(B). Images of abscess lesions taken at day 7, representative of mice infected with strains mentioned in B (C). Measurement of lesion sizes from mice infected with strains as above over a period of 7 days. Measurements were made using Image J (D). Bacterial burdens enumerated per gram of homogenized tissue excised at day 7 post infection with strains as described above (E). Percent distribution of the cna gene as detected in S. aureus clones associated with human skin and soft tissue infections (n=20) and colonizing healthy anterior nares (n=30) (F) Abscess model of skin infection performed as described in A, to compare pathology caused by USA300 (Cna−) and USA300:pcna (Cna+) bacteria (n=5 per group). Weight loss was measured over 7 days and calculated as a percentage of values at day 0 (G). Representative images of lesions formed 7 days post infection with strains mentioned in G (H). Lesion sizes measured over 7 days post infection with strains as described in G. Measurements were made using Image J (I). Colony forming units (CFU) per gram of homogenized tissue enumerated from abscesses biopsied from mice infected with strains as mentioned in G, at day 7 post inoculation (J). Results are representative of 3 (MW2) and 2 (USA300) independent analyses. Statistical analyses were performed with a one-way ANOVA (E) a two tailed Students t-test (I) or a two-way ANOVA with Bonferroni post test. Error was calculated based on SEM. Groups with significant differences are denoted. *P<0.05, **P<0.01, ****P<0.0001.

To gauge the impact of Cna to clinical infections, we assessed the prevalence of the cna gene in S. aureus isolates representing the major clonal types from patients with primary SSTIs36. Of note, 60% of these isolates did not encode for cna. Since nasal colonization is an important risk factor for infection, we also sequenced for the presence of the cna gene across the major clonal types in patients with positive nasal cultures for S. aureus37. We similarly found that ~60% of these isolates did not encode for cna (Figure 1F). These results indicate that the absence of Cna is common and, depending on the population, may predominate in both nasal colonization and SSTIs associated with S. aureus.

We performed a mouse intradermal infection using USA300, a dominant clinical strain of MRSA which does not encode the cna gene38. We infected mice as mentioned above and compared the progression of abscess formation with a USA300 strain engineered to express Cna from the vector used above (USA300:pCna). As expected, we found that USA300 (Cna−) infected mice showed ~10% higher rates of weight loss when compared to the USA300:pCna group (Figure 1G). This was comparable to observations made in mice infected with the Δcna isogenic mutant in the MW2 WT background. Similarly, we observed macroscopically larger abscesses, which was confirmed by measuring lesion sizes over the course of infection (Figure 1H, I). Lastly, these phenotypes were associated with ~2 log higher CFU/g of tissue in USA300 infected animals when compared to the USA300:pCna group (Figure 1J).

Finally, to verify that these phenotypes were not due to sex differences in our mouse experiments, we performed a similar infection study in male, age matched BALB/c mice. Consistent with the results from experiments with female mice of the same background, we found that male BALB/c mice infected with Δcna bacteria had visibly larger abscesses, with larger lesions sizes measured through the course of infection (Figure S1C). While we did not observe significant weight loss, bacterial burdens were similarly ~1–1.5 log higher in Δcna infected mice, as compared with WT and comp cna infected controls (Figure S1D, E). Collectively these data confirm that the expression of Cna is sufficient to restrict the bacterial burden and gross pathology observed during S. aureus skin infection.

Collagen binding dampens the inflammatory response to S. aureus in skin abscesses.

S. aureus skin infections are often associated with an inflammatory immune response that causes worsened pathology39. Hematoxylin Eosin (H&E) staining performed on longitudinal sections of abscess tissue excised at day 7 determined that the worsening of infection phenotypes we observed were indeed associated with the marked accumulation of necrotic tissue (purple) in Δcna infected animals when compared to those infected with either WT or comp cna S. aureus, which were more comparable to control animals injected with saline (pink) (Figure 2A). We therefore utilized a multiplex assay to measure the concentrations of 44 inflammatory cytokines in these tissue samples. We observed a comprehensive increase in the inflammatory response measured from Δcna infected mice (Figure 2B). Specifically, this included significant increases in the concentrations of key markers of inflammation namely IL-6, TNF-a and IL-1b as well as chemotactic factors for hemopoietic cells, KC, MCP-1, G-CSF and GM-CSF. Additionally, infection with Δcna bacteria caused a significant increase in concentration of the tissue inhibitor of matrix metalloprotease-1 (TIMP-1) (Figure 2C). Collectively these results indicate that Δcna bacteria induce a larger skin inflammatory response when compared with an isogenic Cna+ counterpart.

Figure 2. Expression of collagen binding adhesin is sufficient to restrict host inflammatory response.

Figure 2.

Hematoxylin Eosin staining of tissue sections biopsied from mice infected with WT, isogenic Δcna or comp cna bacteria at day 7 post infection. Tissue section of mouse injected with saline is shown as a negative control (A). Cytokine array performed on mouse tissue collected from animals infected as described for A. The multiplexing analysis was performed to measure the concentration of 44 cytokines, using the Luminex 200 system by Eve Technologies Corp. Each column represents results from a single mouse (n=5 per group) (B). Individual graphs to show differences in cytokine measurements as made in B, for 8 cytokines of interest generated from mice in response to respective bacterial strains (C). Quantification of cytokine concentrations similar to B, made from mice infected with USA300 or the isogenic USA300:pcna strain (n=5 per group) (D). Individual graphs shown for 8 cytokines similar to C, measured from abscesses infected with strains as mentioned in D, 7 days post bacterial inoculation (E). Summary of methods used to perform flow cytometry quantification of immune cells from abscesses infected with bacteria as described for A (F). Quantification of the total number of single immune cells using an antibody specific to CD45, from tissue samples collected as described in F, for mice infected with bacterial strains described in A (n=7) (G). Differentiation of cells enumerated in G, based on exclusion of Am Cyan viability dye(live) from observably dead populations (H). Sub populations of total CD45 cells classified as neutrophils (I) or macrophages (J) based on staining with cell specific antibodies as described in Figure S2A, B. Results are representative of 3 independent analyses. Statistical analyses were performed with a one-way ANOVA with a Bonferroni post-test. Error was calculated based on SEM. *P<0.05, **P<0.01, ****P<0.0001

Since S. aureus expresses multiple toxins that can cause host immune cell lysis and acute inflammation, we wanted to confirm that Cna was sufficient to induce these changes in the host. We therefore performed a similar cytokine analysis using the dominant clinical strain, USA300 which does not express Cna. These measurements were performed in comparison to a USA300:pCna, as mentioned for Figure 1. USA300, much like the MW2 Δcna infected mice, showed an overall increase in levels of inflammatory cytokines compared to mice infected with USA300:pCna bacteria (Figure 2D, E).

Alpha toxin is a well-documented dermonecrotic protein expressed by most strains of S. aureus 40,41. To confirm that the phenotypes we observed in mice are not due to the expression of alpha toxin, we performed an intradermal infection as described above, and compared a transposon mutant of hla, the gene encoding the alpha hemolysin protein, with an isogenic hla::Tn Δcna strain in the MW2 strain background. Similar to previous results, the inability to express Cna caused an increase in lesion size, weight loss and CFU burden in the hla::Tn background, indicating that the phenotypes observed were largely independent of alpha toxin (Figure S1FH). Collectively, these results demonstrate that the expression of Cna is sufficient to suppress the acute intradermal inflammatory response to S. aureus infection.

Absence of Cna results in excessive immune cell death.

To quantify immune populations that were contributing to increased inflammation in mice infected with Δcna bacteria, we performed flow cytometry on perfused abscess tissue collected at day 7, using previously published methods42 (Figure 2F, Figure S2A, B). While the total numbers of CD45+ immune cells (as a proportion of total single cells) were comparable between WT, Δcna and comp cna infected groups of mice (Figure 2G), we observed a large disparity in the numbers of live, and dead/dying CD45+ populations between these groups, with Δcna infected tissue samples containing very few live CD45+ cells and a large population of observable dead CD45+ cells compared to WT infected samples (Figure 2H). This phenotype was able to be complemented, as numbers of both live and dead CD45+ cells could be restored to WT levels in mice infected with the comp cna strain. These data indicate that the loss of Cna results in abscesses composed primarily of dead immune cells. Further analysis demonstrated that the observed increase in dead CD45+ cells in Δcna infected animals was driven largely by an increase in (intact but) dead neutrophils (Figure 2I). Interestingly, we did not observe this increase of dead cells within the macrophage population (Figure 2J). Inversely, comparison of Δcna to WT and especially comp cna infected groups confirmed that expression of Cna may promote survival of neutrophils (Figure 2I) and macrophages (Figure 2J), since live populations of these cells were restored to significantly higher levels in comp cna infected tissue. Although to a smaller extent, this decrease in live immune cells was also observed for additional CD45+ populations (Figure S2C). Collectively these results demonstrate a rise in total immune cell death, particularly neutrophils, during infection with S. aureus lacking Cna.

In an attempt to avoid the extensive cell death observed at day 7, we assessed the immune profile of these infections at an earlier time point. Our results indicate that Δcna infected mice develop larger abscesses as early as day 3, when compared to WT and comp cna groups (Figure 1D). H&E staining revealed pathology in Δcna infected mice at day 3 that was similar to that observed at day 7, although the levels of inflammation were less pronounced (Figure S2DG). We observed that gross infection phenotypes were similar to day 7 including weight loss (Figure S3A), lesion sizes (Figure S3B),CFU burdens (Figure S3C) and inflammatory cytokine responses (Figure S3D, E).

We next used the previously described antibody panel to quantify immune cell populations present in day-3 abscess tissue, collected and performed as previously described. Similar to results from day 7, while the CD45+ cells (as a proportion of total single cells) were similar among S. aureus infected groups, we again observed very few live immune cells in Δcna infected lesion tissue, compared to both WT and comp cna infected animals (Figure S3F). Concurrently, we observed significantly higher populations of dead/dying cells in Δcna infected abscesses compared to WT and comp cna infected abscesses, again largely driven by increases in dead neutrophils (Figure S3G). Significantly higher numbers of live macrophages could be observed in WT infected tissues, compared to Δcna samples (Figure S3H). Similar to results at day 7, the decrease in total numbers of live cells was also evident in additional subpopulations of CD45+ cells (Figure S3I). Collectively these results confirm that the absence of Cna results in increased inflammation, likely due to neutrophil death over the course of infection.

Increased uptake of Δcna bacteria causes neutrophil lysis.

Serum complement protein C1q plays an important role in the opsonophagocytosis of S. aureus43. C1q consists of a C-terminal globular head domain that binds to immunoglobulins or directly to the bacterial surface to activate the classical proteolytic pathway that leads to opsonization and phagocytosis of S. aureus44. The N- terminus of C1q is a collagenous tail domain that has previously been shown to bind to Cna derived from S. aureus strain Phillips in vitro and inhibit downstream activation of the classical pathway 22(Figure S4A). To confirm similar in vitro binding of Cna to the C1q N-terminal tail in the MW2 strain background, we utilized a competitive enzyme linked immunosorbent assay with a C1q- coated surface to demonstrate a reciprocal relationship wherein the level of Cna bound to C1q progressively decreased when collagen was incubated in the presence of increasing concentrations of recombinant Cna (Figure S4B). Since we observed increases in populations of dead neutrophils during in vivo infection (Figure 2I), we sought to examine the effect of this interaction on downstream activation of the classical complement pathway. We opsonized WT, Δcna and comp cna and measured bound C3b or C4b. C4b is part of the C3 convertase and is cleaved to activate C3b, an opsonin with a central role in the complement pathway23,44. Using flow cytometry, we confirmed that Δcna bacteria exhibited significantly higher levels of C4b (Figure 3A) and C3b (Figure 3B) deposition, compared with both WT and comp cna strains. Consistent with the previous study, these results indicate that the presence of Cna reduces opsonization of bacteria by the classical complement pathway22. To assess the effect of this Cna mediated inhibition of C1q specifically on phagocytic activity, we measured bacterial uptake in the presence of primary human neutrophils using previously published methods4547. We observed a significant increase in the uptake of Δcna bacteria (~20%) when compared to neutrophils exposed to WT or comp cna for 10 minutes (Figure 3C). To attribute a direct role to C1q in this process, we opsonized bacteria with C1q-depleted serum prior to performing the experiment. We found no significant differences in uptake between WT, Δcna and comp cna under these conditions (Figure 3D). Collectively these results suggest that Cna binds to serum C1q, reducing complement activation and subsequent phagocytic uptake by neutrophils.

Figure 3. Cna binds to collagen motifs to alter the neutrophil response to bacteria.

Figure 3.

Flow cytometry of WT, Δcna or comp cna bacteria opsonized with 10% serum and stained with antibodies targeting serum complement proteins C4b (A) and C3b (B). Uptake of bacterial strains mentioned above by primary human neutrophils, following opsonization with 10% pooled human serum. CFU was enumerated 10 minutes post incubation, following which samples were treated with lysostaphin to exclude extracellular populations (C). Experiment similar to C performed with bacteria opsonized with 10% C1q-depleted, pooled human serum (D). Experiments similar to C, with intracellular (E) and total (F) bacterial survival calculated at 30 minutes post incubation. Confocal microscopy performed on respective bacterial strains (Green=Syto-9/live) opsonized as mentioned above in the presence of type 1 collagen and incubated with Cell Tracker Blue-labelled primary human neutrophils for 20 minutes, following which samples were stained with ethidium homodimer-1 (red) to visualize dead/dying cells. Arrows indicate likely location of collagen boundary (G- I). Statistical analyses were performed with a one-way ANOVA and Bonferroni post-test. Error was calculated based on SEM. *P<0.05, **P<0.01, ****P<0.0001

We hypothesized that the increase in opsonophagocytic activity observed in response to Δcna results in neutrophil death. We therefore measured bacterial survival 30 minutes post incubation with neutrophils and observed significantly lower numbers of intracellular Δcna bacteria, compared to neutrophils that were exposed to WT or comp cna S. aureus (Figure 3E). To understand if this was due to neutrophil lysis, bacterial release, and inadvertent killing due to lysostaphin treatment, we measured bacterial survival in the absence of lysostaphin. We observed a significantly larger population of surviving Δcna bacteria compared with both the WT and comp cna under these conditions (Figure 3F). These observations confirm that the Cna-C1q interaction decreases phagocytic uptake by neutrophils, inadvertently allowing for controlled, efficient killing of the pathogen by these cells. Conversely, in the absence of Cna, we find that neutrophils increasingly phagocytose bacteria which results in cell death and release of Cna-negative S. aureus.

Cna interacts with collagen to restrict neutrophil access to bacteria.

Since both collagen and C1q would be present and capable of binding to WT Cna+ bacteria in vivo, we performed confocal microscopy on bacteria opsonized in the presence of collagen and incubated with primary human neutrophils as described above. Binding to collagen restricted the direct access of neutrophils to WT (Figure 3G) and comp cna bacteria (Figure 3I). Loss of Syto-9 staining in bacteria closest to the periphery of the collagen-bound aggregate indicated bacterial killing (Figure 3G, I white arrows). In sharp contrast, Δcna bacteria largely caused lysis of neutrophils as evidenced by ethidium homodimer-1 staining. Similar to results from the opsonophagocytosis assay, we observed large numbers of Syto-9 labeled, extracellular Δcna bacteria, indicating bacterial survival (Figure 3H). Together these results indicate that binding to collagen allows for controlled, efficient clearance of bacteria. Conversely, neutrophils have direct access to Δcna bacteria even in the presence of collagen, inadvertently causing them to lyse.

To assess the consequence of the collagen- Cna interaction in vivo, we performed multispectral imaging on tissue sections collected 3 days post infection (Figure 4A). WT/Cna+ S. aureus was observed as DAPI- stained aggregates surrounded by collagen (Figure 4B). These were confirmed to be bacteria using a modified Gram stain (Figure S4C). We found that macrophages and neutrophils were present but restricted from the infection in WT infected abscesses (Figure 4B). In contrast, Δcna infections showed a higher number of neutrophils and decrease in observable macrophages, both in close juxtaposition to bacteria, which were more diffused compared to both WT and comp cna infected tissue (Figure 4CD). Quantification of these immune cells in the tissue section corroborated our previous flow cytometry results to show comparable levels of CD45+ populations with higher numbers of neutrophils (~30%) in Δcna infected samples compared to both WT and comp cna sections (Figure 4E). Together these results indicate that the absence of collagen and therefore direct contact of bacteria with immune cells, causes a dysfunction in the neutrophil and macrophage response to infections resulting in bacterial persistence and an exaggerated inflammatory response.

Figure 4. S. aureus- collagen aggregates trigger increased neutrophilic response in skin abscess infection.

Figure 4.

Multispectral quantitative pathology of skin abscess tissue excised from mice infected with WT, Δcna or comp cna bacteria 3 days post inoculation and stained with antibodies targeting 6 host proteins as described in the legend. Images depict staining of entire tissue section as used for quantitative analysis (A). Images digitally zoomed in (X5.9) from sections shown in A. Regions of interest are depicted in A as blue boxes. Images demonstrate staining from tissues infected with WT (B) Δcna (C) or comp cna (D) and stained with antibodies targeting 6 host proteins as shown in legend. Images are separated according to channels that demonstrate spatial distribution of bacteria with collagen (DAPI, Collagen), neutrophils (CD45, CD11b) and macrophages (CD45, F480). Quantification of staining demonstrated in A represented as total cells per millimeter of tissue sections infected with strains as described above (E).

Cna-C1q interaction dampens inflammation caused in response to S. aureus in vivo.

C1q plays a central role in the opsonophagocytic response of neutrophils to bacteria44. Since C1q binds Cna in addition to collagen, we performed an experiment similar to (Figure 3GI), with bacteria that were opsonized with C1q depleted serum before incubation with human neutrophils. Under these conditions, we observed that neutrophils gained access to the collagen bound aggregates of WT and comp cna bacteria. This was associated with neutrophil lysis similar to the response generated to Δcna bacteria in both C1q replete and depleted conditions. WT and comp cna were observed to elicit a response similar to Δcna bacteria, in the absence of C1q (Figure S4DF). To evaluate the contribution of the C1q-Cna interaction in vivo, we used the previously described abscess model of skin infection in C1q knockout mice (hereafter C1qKO) of the C57BL/6 WT background. Since our observations were made in the BALB/c mouse background, we performed a direct comparison of infection between C57BL/6 WT and C1qKO mice. Similar to previous results, we found that infection of C57BL/6 WT mice with Δcna bacteria resulted in a ~1.5 log increase in bacterial burdens (Figure 5A) and visually bigger abscess lesions that were significantly larger than both WT and comp cna infected animals when quantified (Figure 5B). We therefore measured the levels of inflammatory cytokines present in WT C57BL/6 abscesses and observed results similar to infections performed in female BALB/c mice (Figure S5A), with Δcna infected abscesses containing significantly higher concentrations of key inflammatory markers when compared to both WT and comp cna groups (Figure S5B). To understand the role of the C1q-Cna interaction in this model we similarly infected C1qKO mice with WT, Δcna or comp cna bacteria and observed an overall increase in the bacterial burden of WT and Δcna infected animals retrieved at day 7, when compared with WT C57BL/6 infections (Figure 5A). Additionally, we observed a reduction in bacterial CFU loads (~1 log) between WT and Δcna infected mice. Similarly, the differences between WT and Δcna lesions sizes were smaller in the C1qKO mouse background (Figure 5B, C). Lastly, the overall levels of inflammatory cytokines generated in the C1qKO infection background were higher and comparable between WT and Δcna infected mice, once again demonstrating that C1q dampens inflammation in the presence of Cna (Figure 5D, Figure S5C).

Figure 5. C1q-Cna binding controls matrix metalloprotease activity and inflammation in skin abscess.

Figure 5.

CFU per gram of homogenized tissue enumerated from either WT BL57 or C1qKO mice, 7 days post infection with WT, Δcna or comp cna bacteria (A). Representative images of lesions formed at day 7 post infection of WT BL57 (B) or C1qKO (C) mice with strains described in A (top). Lesion sizes measured over the course of the infection for each strain (n=10 per group, bottom). Comprehensive view for the concentrations of 44 inflammatory cytokines measured from abscess tissue 7 days after infection with respective bacteria, in the C1qKO mouse background. Concentrations are presented in logarithmic scale of picogram per mL homogenized tissue. Each column represents results from a single mouse (n=5 per group)(D). Graphical depiction of the known mechanisms by which matrix metalloproteases 9 and 12 can instigate a cascade of neutrophil and macrophage mediated inflammation of skin infection sites (E). Concentrations of MMP-2, pro-9 and 12 measured from abscess tissue excised from WT BL57 (F) or C1qKO (G) mice infected with respective strains. Concentrations of leukotriene A-4 hydrolase (LTAH4) measured using an enzyme linked immunosorbent assay, from WT BL57 mice infected with bacterial strains as described in G (H). Assay similar to H measuring the concentrations of leukotriene B4 from homogenized tissue samples (I). Assay similar to H, quantifying the concentrations of LTAH4 and performed with tissue samples from C1qKO mice infected with bacterial strains as described in H (J). Results are representative of 2 independent analyses. Statistical analyses were performed with a two-way ANOVA (B, C) or a one-way ANOVA (A, F-J) with Bonferroni posttest. Error was calculated based on SEM. *P<0.05, **P<0.01

Altogether our in vitro and in vivo results demonstrate that the absence of C1q increases severity of infection pathology and the Cna-C1q interaction results in WT S. aureus phenotypes that are similar to those observed in Δcna infected animals.

Tissue matrix metalloproteases contribute to macrophage dysfunction and excessive neutrophil influx.

We observed a significantly higher level of the tissue inhibitor of matrix metalloprotease-1 (TIMP-1) measured from Δcna infected mouse tissue, when compared to WT and comp cna groups at both day 3 (Figure S3E) and 7 (Figure 2C, E) post infection. This suggested that the host immune system may attempt to control the levels of inflammatory MMPs in the tissue bed during Δcna infection. MMP-2 and 9 are gelatinases that also bind to collagen, while MMP-12 is a macrophage elastase30,48. MMP-9 is specifically released by neutrophils in response to the small molecule mediator, leukotriene B4 (LTB4), from macrophages49. MMP-9 degrades collagen to form the proinflammatory, neutrophil chemotactic peptide, Pro-Gly-Pro which functions by binding CXCR1/2, resulting in recruitment of additional neutrophils to the site of infection (Figure 5E). This would result in increased levels of the cytokine KC, similar to our observations at day 3 (Figure S3E) and 7 (Figure 2E).

Concentrations of MMP-2, 9 and 12 measured from abscess tissues were significantly higher in Δcna infected tissues when compared to WT and comp cna groups (Figure 5F). Since both the C-terminal globular domain and N- terminal collagen tail of C1q are recognized by macrophages via the gC1qR and cC1qR/calreticulin receptors respectively, we asked whether this inflammatory cascade was disrupted in the absence of C1q. While C1qKO mice showed higher levels of all MMPs measured, when compared to WT mice, levels of MMPs in WT and comp cna infected groups were comparable with those measured from Δcna infected mice (Figure 5G). To terminate this inflammatory cycle, proinflammatory, MMP-12- secreting macrophages release leukotriene A4 hydrolase (LTAH4) which directly binds and inactivates Pro-Gly-Pro33. Δcna infected mice contained significantly higher levels of LTAH4 compared with WT and comp cna groups (Figure 5H). Since LTAH4 is also required for the formation of LTB4, we reasoned that LTAH4 binding to increased levels of Pro-Gly-Pro would reciprocally limit the concentrations of released LTB4. Indeed, we observed a significant reduction in concentrations of this small molecule in Δcna infected animals, compared with WT and comp cna infected mice (Figure 5I). Furthermore, these differences were found to be abrogated when LTAH4 was measured from C1q KO mouse infections (Figure 5J). Together these results indicate that the local cycle of inflammation caused by the direct interaction of macrophages and neutrophils with Cna negative S. aureus, is also tempered by the presence of C1q.

Discussion

Studies characterizing the cna gene of S. aureus were performed over a decade ago18,50. Our knowledge of its importance to S. aureus pathogenesis, however, is extremely limited. Published reports were in three infection environments, namely eye, heart and bone, utilizing the less characterized strains of S. aureus: Phillips and CYL31620,50,51. These previous studies do not examine Cna in the context of skin colonization or SSTIs despite the essential role for collagen in the resolution of skin infection and the overwhelming presence of S. aureus in a majority of purulent SSTIs52,53. Here we provide a comprehensive analysis for the role of Cna, specifically during S. aureus skin infections. We demonstrate that the inability to directly bind collagen is associated with worsened outcomes (Figure 1AE), and that Cna− negative S. aureus is prevalent among major skin clones (Figure 1 F).

Multiple comparative analyses that investigate the role of adhesins to inflammation caused during S. aureus- associated skin infection, do not identify Cna as an important virulence determinant54. In one study that included skin samples from patients with atopic dermatitis, psoriasis and normal skin colonized with S. aureus, absence of Cna expressed from S. aureus resulted in no observable decrease in bacterial binding to the stratum corneum55. Our studies demonstrate that Cna is sufficient and necessary to reduce the severity of skin infection caused by the predominant, clinically relevant, USA300 strain (Figure 1GJ). Further studies to specifically characterize the prevalence of isolates lacking the cna gene are therefore imperative to our knowledge of S. aureus skin infections. Of note, Panton Valentine leukotoxin (PVL) is epidemiologically linked to primary, purulent SSTIs 5658. MW2 and USA300, the strains used in our study, both express PVL, indicating that the phenotypes observed here are likely not associated with the expression of this toxin.

Biochemical characterization of the Cna protein from strain Phillips, identifies the N-terminal A domain as the ligand binding region of the protein16. This domain can bind to complement protein C1q and prevent the opsonization of S. aureus 22. Authors in these studies used RBC lysis as a functional read out of complement activation. Here we additionally demonstrate opsonophagocytosis as a more relevant downstream effect (Figure 3 AC)59,60. By using primary human neutrophils, we build on previous findings to show that when C1q is not sequestered by binding to Cna, this results in a likely uncontrolled mechanism of cell death with increased neutrophil lysis accompanied by bacterial survival (Figure 6A, B). Therefore, competition between collagen and C1q for binding to Cna correlates with the downstream neutrophil response, and the ability to fine tune ligand binding (collagen vs C1q) is necessary to protect S. aureus from immune clearance mechanisms22. Indeed, when Cna is ectopically expressed from a high copy expression vector, bacterial survival in C1qKO mice is comparable to WT and comp cna S. aureus, in WT C57BL/6 mice, indicating that increased binding to collagen may compensate for the absence of binding events that occur with the C1q N-terminal domain (Figure 5A).

Figure 6. Summary of results.

Figure 6.

Expression of Cna allows S. aureus to bind to collagen and restrict bacterial contact with immune cells such as neutrophils. The N-terminal collagen like domain of C1q binds to Cna and reduces complement deposition and opsonophagocytosis by neutrophils. Bacteria that are taken up are eliminated by neutrophils (A). Bacteria lacking the ability to express Cna cannot directly bind to collagen. This allows direct contact between neutrophils and bacteria. C1q is not sequestered in the absence of Cna, causing increased bacterial uptake by neutrophils. This leads to neutrophil lysis and inflammation (B). Macrophages in the infection bed will release proinflammatory mediators including the matrix metalloprotease MMP-2, MMP-12 and neutrophil chemokine, IL-8. Macrophages also express leukotriene A4 hydrolase (LTAH4) in response to infection, which activates the soluble effector, leukotriene B 4 (LTB4). Neutrophils release MMP-9 which breaks down collagen to inflammatory Pro-Gly-Pro which assists in further neutrophil recruitment (C). Image created using Biorender.com

It is likely that while Cna-C1q binding affects opsonization and uptake of bacteria as shown here, toxins released by S. aureus are responsible for bacterial escape and neutrophil lysis. Leukotoxins are widely characterized as causing immune cell lysis, with LukAB being particularly significant at allowing intracellular bacteria to lyse neutrophils from within 6163. This activity occurs in concert with alpha hemolysin (Hla), a secreted, pore forming toxin64,65.Further studies that expand on the effect of Cna and its interactions with host ligands, with emphasis on the neutrophil response to S. aureus, are required in order to further evaluate potential roles for these toxins.

Our results provide additional evidence for the vital role that macrophages play during resolution of skin infections (Figure 6C)66. In this work, the absence of viable macrophages was accompanied by increased numbers of dead neutrophils and prolonged inflammation in mice infected with Δcna bacteria, providing further validation of the communication between neutrophils and macrophages that is essential for resolution of skin infection. Hla has documented roles in macrophage lysis, leading to reduced neutrophil infiltration and bacterial clearance during skin infection 67. Increased bacterial survival in the absence of Cna may result in higher local concentrations of Hla and therefore more lysed macrophages. Whether Hla plays an additional role in the lack of live macrophages observed in our studies, remains to be assessed and would provide a deeper understanding of the triggers that cause macrophage activation, small molecule release and therefore neutrophil infiltration. Similarly, the increased concentrations of matrix metalloproteases may be a direct effect of the presence of a larger number of lysed neutrophils. One report indicates that matrix metalloproteases 1, 2, 3 and 9 can cleave the collagen-like domain of C1q and result in neutrophil reactive oxygen burst. This may contribute to the killing of bacteria that are exposed to neutrophils (Figure 4 G- I)68. Lastly, while we see a rise in observable, dead neutrophils when mice are infected with Δcna bacteria, we do not observe these differences in macrophage populations at the timepoints examined (Figure 2J). Macrophages can suffer numerous fates following resolution of inflammation including conversion to endothelial cells or fibroblasts69. Recently, fibroblasts have been demonstrated to be an important source of collagen that is utilized as nutrition by S. aureus during pulmonary infections. Of note, these studies were performed in strains that do not express Cna70. The fate and function of macrophages and monocytes following exposure to S. aureus in the context of Cna, remains to be resolved 71,72.

Results presented here translate in vitro experiments for the first time to demonstrate a direct association between the Cna-C1q interaction and control of inflammation in vivo (Figure 5AD). It is important to note however, that C1q is one of many host proteins that contain a collagen-like motif, any of which could be present in the abscess microenvironment and contribute to sequestration of available ligand binding domains on Cna73,74. Additionally, host proteins that bind the N-terminus of C1q, such as MBL- associated serine proteases, could compete with Cna for binding75. Similarly, most studies focus on the ability of Cna to bind type 1 collagen. The ratio of type 1/3 collagen is crucial for wound healing and most matrix metalloproteases bind multiple types of collagens. This may influence the outcome of infection in the context of Cna, and remains to be studied48,76.

USA300 (Cna−) and MW2 (Cna+) are both successful, clinically isolated strains of S. aureus that differ in their ability to express Cna7,13,77. This, together with our findings indicates that rather than determining bacterial survival, the expression of Cna may dictate the nature and length of infection caused by S. aureus, as well as the degree of inflammation achieved as a consequence.

Our current work reveals that rather than assisting in infection exacerbation and dissemination of S. aureus such as would be expected of a canonical virulence factor, Cna is involved in concealing bacteria from the immune system and quiescently establishing an infection bolus, likely until favorable conditions for growth become unavailable and dissemination is required for survival. These findings also indicate that the loss of cna may have provided an evolutionary advantage to make S. aureus prolific at dissemination78,79. Conversely, expression of Cna by a subset of strains may allow them to persist for long periods in the community, either as colonizers or as chronic, biofilm associated infections 20,50,51.

S. aureus cells expressing Cna accumulate collagen which may serve as a ‘self’ signal that allows immune evasion. Bacteria afford the time required to proliferate and form a collagen shield by binding to collagen like domains of the major innate, bacterial recognition protein, C1q. This function potentially extends to additional pathogen recognition molecules, many of which express similar domains73,74. Additionally, bacteria that are recognized and engulfed by immune cells presumably utilize one or more bacterial toxins to kill these cells, allowing S. aureus to survive47,80,81. We demonstrate that the loss of cna promotes the expansion of S. aureus infection. It is well established that when S. aureus is present in sufficient numbers, it is not easily eliminated by the immune system47,80,82. Our results with skin infections confirm this and show that this results in massive immune cell death, likely caused due to bacterial virulence properties that are similar to Cna expressing cells. The zone of necrotic cells, largely neutrophils, presumably shields bacteria from the entry and function of additional immune cells into the infection bolus. Altogether, this work establishes a major role for Cna in S. aureus skin infections and demonstrates its significant immune evasion properties.

Resource availability

Lead Contact

Further inquiries and information on reagents and resources should be directed to (and will be fulfilled by) the lead contact, Alexander R. Horswill. (alexander.horswill@cuanschutz.edu)

Materials availability

Reagents and materials used or generated in this study can be made available upon request from the lead contact.

Data availability

Data reported in this manuscript will be made available by the lead contact upon request.

Ethics Statement.

Experiments with animals were reviewed and approved by the institutional animal care and use committee at the University of Colorado Anschutz Medical Campus (IACUC #00486) Primary human neutrophils were isolated from healthy human donors after obtaining informed, written consent from each donor. This was done according to the protocol approved by the University of Colorado Anschutz Medical Campus institutional review board (IRB #17–1926).

Materials and Methods

Bacterial strains and growth conditions.

Unless otherwise indicated, all strains of Staphylococcus aureus were grown in tryptic soy broth (TSB) at 37°C with shaking. Overnight bacterial suspensions were sub-cultured and grown to exponential phase for all in vitro assays. This corresponded to an optical density of 0.42 (O.D. 600). Antibiotics were added during growth where indicated. E. coli ER2566 was grown in Luria Bertani Broth using methods described below for protein purification.

Generation of bacterial mutants and complementation.

Chromosomal deletion of the cna gene were performed using previously established methods83. Briefly, the temperature sensitive pJB38 plasmid was used to introduce DNA fragments (~1kb) flanking the target region of interest. Flanking DNA was amplified (Phusion high fidelity polymerase, NE Biolabs) using gene specific primers, products were digested with restriction enzymes and purified (Qiagen PCR purification). Following triple ligation into pJB38, the plasmid was electroporated into E. coli DC10B and selected for on Luria Bertani agar plates containing 100 μg/mL ampicillin. Following confirmation from single colonies, plasmid was purified, PCR used for confirmation with construction and sequencing primers performed and plasmid was electroporated into S. aureus. Positive clones were selected on tryptic soy agar (TSA) containing 10 μg/mL chloramphenicol and homologous recombination performed at 42°C for 24 hours. Following overnight incubation in TSA-Cam and a series of subcultures in TSB at 30°C, counterselection was performed on 200 ng/mL anhydrotetracycline (30°C/overnight). Loss of plasmid was indicated by growth on TSA but not TSA-Cam and presence of desired mutation was verified using PCR with chromosomal primers that were outside the region of mutation. The cna complementing plasmid was generated by amplifying cna with its promoter region using the Q5 polymerase from WT MW2 genomic DNA using the primers:

F-ctcggtaccttaggaggatgattatttatgaacaagaacgtgttgaa

R- acagctatgacatgattacgaattcttatgagttaaatctttttcttaaaattaaatac

KpnI and EcoRI were used to digest this fragment which was subsequently ligated into pCM28 digested with the same enzymes. Plasmid was confirmed and maintained with 10 μg/mL chloramphenicol.

Murine skin abscess model of infection.

All infections were performed on 7-week-old mice by inoculating 1X108 CFU/mL bacteria intradermally as previously described34,35. Briefly overnight bacterial cultures were sub-cultured and grown to an appropriate OD and resuspended in saline. Mouse stomachs were shaved and treated with Nair, hair removal cream, one day prior to inoculation of bacteria. Abscess formation was monitored with imaging over the span of 7 days. Mouse weight loss was measured daily. On day 7, mice were sacrificed, and abscesses excised using a 6mm punch biopsy. Abscess tissue was resuspended in 500uL phosphate buffered saline and homogenized with physical disruption using (0.1mm beads, Biospec Mini- Beadbeater). Colony forming units were calculated from homogenate and plotted per gram of tissue.

Detection of cna from clinical isolates.

We assessed the presence of cna by analyzing the genome sequences of isolates representing the major clonal types of methicillin-susceptible and -resistant S. aureus isolates from two previously published studies of primary purulent SSTI and nasal colonization36,37. Briefly, libraries were prepared and sequenced at the NYU Langone Genome Technology Center using an Illumina NovaSeq to produce paired-end 150 bp reads. Reads were filtered and trimmed with fastp v0.20.1 using default settings84. Confindr v0.7.4 identified within-species contamination, and isolates with >10% contamination were excluded85. Filtered reads were then assembled with Unicycler v0.4.8 in conservative mode86. Taxonomic classification of assemblies was performed using GTDBTK v1.5.1; non–S. aureus isolates were excluded87. S. aureus sequence types and clonal complexes were determined with MLST (https://github.com/tseemann/mlst). We used BLAST v2.12.0+ to search for the cnaB gene with the KEGG sequence (ID: MW2612), considering a genome cnaB positive if a BLAST hit showed an E-value < 10 2 88,89.

Mouse histology.

Abscess tissue was fixed in 10% formalin and submitted to the Gates Histology Services Core Lab (University of Colorado Anschutz Medical Campus) for microtomy and hematoxylin-eosin staining.

Cytokine measurements.

Cytokine concentrations were measured from mouse tissue homogenate that was treated with protease inhibitor (Sigma) and stored in PBS at −80°C before being analyzed by Eve Technologies. Briefly the multiplexing analysis was performed using the Luminex 200 system (Luminex, Austin, TX, USA) by Eve Technologies Corp. (Calgary, Alberta). Forty-five markers were simultaneously measured in the samples using Eve Technologies’ Mouse Cytokine 45-Plex Discovery Assay®. Assay sensitivities of these markers range from 0.3 – 30.6 pg/mL for the 45-plex. Individual analyte sensitivity values are available in the MilliporeSigma MILLIPLEX® MAP protocol.

Murine skin abscess flow cytometry.

Murine model of skin abscess infection with S. aureus was performed as described above. Skin abscesses were harvested using a 6mm biopsy punch following perfusion of the animal with PBS and heparin. Skin punches were minced and incubated for 2 hours at 37 C with shaking in RPMI 1640 with Miltenyi Multi Tissue Dissociation Kit 1 enzymes (volumes according to the manufacturer). Following enzymatic digestion, samples were mechanically digested using the Miltenyi Gentle Macs dissociator (program “Multi H”). Single cell suspensions were prepared from digested abscess samples by filtering samples through a 70 mm cell strainer and pelleting cells by centrifugation (300 × g, 5 minutes). Remaining red blood cells were removed by resuspending the cell pellet in red blood cell lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA; pH 7.2) for 2 minutes at room temperature and washing with RPMI 1640 (Gibco). Cells were then pelleted by centrifugation and resuspended in MACS buffer (Phosphate buffered saline with 0.5% BSA and 2 mm EDTA, pH 7.2). Single cell suspensions were first stained with eBioscience Fixable Viability Dye eFluor 506 (Catalog # 65–0866-18) in PBS for 30 minutes at room temperature. Cells were stained with the anti-mouse surface antibodies in MACS buffer for 30 minutes at room temperature (See Supplemental Figure 2B for details on antibodies). After surface antibody staining, the cells were fixed (30 minutes at room temperature) using the FoxP3 fixation/permeabilization kit (Thermo Fisher Scientific, Catalog # 00–5523-00). Stained cells were analyzed on a BD LSRFortessa (BD Biosciences) using the BD FacsDiva software (v9) or Cytoflex. Data were analyzed with BD FlowJo software v 10.10.0. Gating strategy was adapted from a previous study and can be found in Supplemental Figure 2A42.

C4b and C3b binding assays:

To measure the differences in C3 binding between various strains, bacteria were grown overnight in TSB and brought up to an O.D of 0.42 were washed 3 times with PBS and re-suspended in 10% pooled human serum for 30 minutes. After repeating the washing step, each sample was stained with rabbit monoclonal Alexa Fluor 647-labelled anti-C3 antibody (Abcam ab196639) or FITC labeled anti-C4b antibody (Thermo Fisher, PA1–28407) for 30 or 20 minutes respectively, at room temperature. Samples were then washed 3 times with PBS and resuspended in PBS for analysis by flow cytometry, using the BD LSR Fortessa (BD Biosciences) and BD FacsDiva software (v9).

Neutrophil isolation.

Isolation of primary human neutrophils was performed using whole blood collected from healthy, consenting human volunteers. Methods used are as previously described46. Briefly, whole blood components were separated using a Ficoll Hypaqe based density gradient. Following removal of peripheral blood monocytes and lymphocytes, red blood cells were lysed with water and remaining neutrophils were resuspended in 0.9% sodium chloride. Following re-suspension in phosphate buffered saline neutrophils were enumerated using a hemocytometer. Neutrophils were used at a concentration of 4X106cells/mL as previously published46.

Neutrophil opsonophagocytosis assays.

S. aureus was incubated with primary, blood-derived human neutrophils isolated as previously described46. To do this, overnight cultures of bacteria grown in tryptic soy broth were diluted 1:100 into fresh medium and grown to an O.D of 0.42, corresponding to ~1X108 CFU/mL. Cultures were then washed 3 times with phosphate buffered saline (PBS) and re-suspended in 10% pooled human serum (Complement Tech) for 30 minutes, in order to opsonize bacteria. Cultures were washed 3 times with PBS and resuspended in 4X106 neutrophils/mL, to bring the multiplicity of infection to 1 (neutrophil): 25 (Bacteria). Samples were then incubated at 37 degrees for 10 (uptake) or 30 (survival) minutes and treated with 10ug/mL lysostaphin for 5 minutes to eliminate extracellular bacteria, as previously described45. Intracellular bacterial survival was assessed by plating serial dilutions on tryptic soy agar. Percent survival was calculated by comparing survival for each strain at 10 and 30 minutes, to its bacterial inoculum present at time 0.

Neutrophil confocal microscopy.

Bacterial strains were opsonized as described above either with 20 μg/ml type I rat tail collagen (Corning®, Cat No: 354236), or without collagen as a control. Staining was performed using previously published methods47. Briefly, neutrophils were isolated as described above (4X106/mL) and stained with Cell Tracker Blue CMAC (Thermo Fisher, Cat No: C2110). Opsonized bacteria labelled with Syto-9 (Invitrogen, Cat No: S34854) were washed and incubated with neutrophils (1:25) for 20 minutes, similarly to method described above. Samples were washed (X3 PBS) and centrifuged (800g) for 15 minutes, pellets re-suspended in minimal volume and mounted onto glass slides with Pro Long Gold Antifade (Invitrogen, Cat No: P36930) with coverslips. Images were collected using the Olympus FV1000 confocal laser scanning microscope (Advanced Light Microscopy Core, University of Colorado Anschutz Medical Campus).

Matrix metalloproteinase measurements.

MMP concentrations were measured from mouse tissue homogenate that was treated with protease inhibitor and stored in PBS at −80°C before being analyzed by Eve Technologies. Briefly, the multiplexing analysis was performed using the Luminex 200 system (Luminex, Austin, TX, USA) by Eve Technologies Corp. (Calgary, Alberta). Five markers were simultaneously measured in the samples using Eve Technologies’ Mouse MMP 5-Plex Discovery Assay® (MilliporeSigma, Burlington, Massachusetts, USA) according to the manufacturer’s protocol. The 5-plex consisted of MMP-2, MMP-3, MMP-8, proMMP-9 and MMP-12. Assay sensitivities of these markers range from 1.6 – 8.4 pg/mL for the 5-plex. Individual analyte sensitivity values are available in the Millipore Sigma MILLIPLEX® MAP protocol

Measurement of LTAH4 and LTB4 from abscess tissue.

Enzyme linked immunosorbent assays were performed to measure the concentration of LTAH4 (Biomatik, Cat No: EKN46742–96T) and LTB4 (Avantar, Cat No: 76576–968) according to the manufacturer’s protocol. Quantification was done using abscess tissue that was biopsied on the same day (day 7 post infection), homogenized as described above and re-suspended in PBS to be used immediately.

Immunofluorescence staining.

Performed on paraffin embedded tissue sections excised from 7-week-old, female BALB/c mice which were euthanized 3 days post inoculation with WT, Δcna or comp cna bacteria, or saline as a negative control. Analysis done by the Human Immune Monitoring Shared Resource, University of Colorado Cancer Center

Supplementary Material

Supplement 1
media-1.docx (3.5MB, docx)

Acknowledgments.

The authors would like to thank members of the Horswill and Doran groups for their critical evaluation of the data in this manuscript. We also acknowledge the Human Immune Monitoring Shared Resource (RRID:SCR_021985) within the University of Colorado Human Immunology and Immunotherapy Initiative and the University of Colorado Cancer Center (P30CA046934) for their expert assistance in analysis of multispectral quantitative pathology. We thank Laura Hoaglin HT(ASCP) with the Gates Histology Services Core Lab (University of Colorado Anschutz Medical Campus) for microtomy and hematoxylin-eosin staining. B.S is funded by the National Institutes of Health (NIH) awards R01AI137336 and R01AI140754. K.S.D is funded by NIH awards R01NS116716 and R01AI153332. A.R.H is funded by NIH award AI083211 and the Department of Veteran’s Affairs award BX002711.

Footnotes

Declaration of interests. The authors declare no competing interests.

References

  • 1.Ricard-Blum S. (2011). The Collagen Family. Cold Spring Harb Perspect Biol 3, 1–19. 10.1101/CSHPERSPECT.A004978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mathew-Steiner S.S., Roy S., and Sen C.K. (2021). Collagen in Wound Healing. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Valotteau C., Prystopiuk V., Pietrocola G., Rindi S., Peterle D., De Filippis V., Foster T.J., Speziale P., and Dufrêne Y.F. (2017). Single-Cell and Single-Molecule Analysis Unravels the Multifunctionality of the Staphylococcus aureus Collagen-Binding Protein Cna. ACS Nano 11, 2160–2170. 10.1021/ACSNANO.6B08404. [DOI] [PubMed] [Google Scholar]
  • 4.Del Giudice P. (2020). Skin Infections Caused by Staphylococcus aureus. Acta Derm Venereol 100, 208–215. 10.2340/00015555-3466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Esposito S., Noviello S., and Leone S. (2016). Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis 29, 109–115. 10.1097/QCO.0000000000000239. [DOI] [PubMed] [Google Scholar]
  • 6.Kaye K.S., Petty L.A., Shorr A.F., and Zilberberg M.D. (2019). Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clinical Infectious Diseases 68, S193–S199. 10.1093/CID/CIZ002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Carrel M., Perencevich E.N., and David M.Z. (2015). USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013. Emerg Infect Dis 21, 1973–1980. 10.3201/EID2111.150452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Otto M. (2014). Staphylococcus aureus toxins. Curr Opin Microbiol 17, 32–37. 10.1016/j.mib.2013.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dal Peraro M., and van der Goot F.G. (2016). Pore-forming toxins: ancient, but never really out of fashion. Nat Rev Microbiol 14, 77–92. 10.1038/nrmicro.2015.3. [DOI] [PubMed] [Google Scholar]
  • 10.Bhattacharya M., and Horswill A.R. (2024). The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections. FEMS Microbiol Rev 48, 2. 10.1093/femsre/fuae002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997–1999. - PubMed https://pubmed.ncbi.nlm.nih.gov/21033181/. [PubMed] [Google Scholar]
  • 12.Groom A. V., Wolsey D.H., Naimi T.S., Smith K., Johnson S., Boxrud D., Moore K.A., and Cheek J.E. (2001). Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286, 1201–1205. 10.1001/jama.286.10.1201. [DOI] [PubMed] [Google Scholar]
  • 13.Vignaroli C., Varaldo P.E., and Camporese A. (2009). Methicillin-Resistant Staphylococcus aureus USA400 Clone, Italy. Emerg Infect Dis 15, 995. 10.3201/EID1506.081632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Golding G.R., Levett P.N., McDonald R.R., Irvine J., Quinn B., Nsungu M., Woods S., Khan M., Ofner-Agostini M., and Mulvey M.R. (2011). High Rates of Staphylococcus aureus USA400 Infection, Northern Canada. Emerg Infect Dis 17, 722. 10.3201/EID1704.100482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mazmanian S.K., Liu G., Ton-That H., and Schneewind O. (1999). Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285, 760–763. 10.1126/SCIENCE.285.5428.760. [DOI] [PubMed] [Google Scholar]
  • 16.Zong Y., Xu Y., Liang X., Keene D.R., Höök A., Gurusiddappa S., Höök M., and Narayana S.V.L. (2005). A ‘Collagen Hug’ Model for Staphylococcus aureus CNA binding to collagen. EMBO J 24, 4224–4236. 10.1038/SJ.EMBOJ.7600888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Thomas M.G., Peacock S., Daenke S., and Berendt A.R. (1999). Adhesion of Staphylococcus aureus to Collagen Is Not a Major Virulence Determinant for Septic Arthritis, Osteomyelitis, or Endocarditis. J Infect Dis 179, 291–293. 10.1086/314576. [DOI] [PubMed] [Google Scholar]
  • 18.Nilsson I.M., Patti J.M., Bremell T., Höök M., and Tarkowski A. (1998). Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. Journal of Clinical Investigation 101, 2640–2649. 10.1172/JCI1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Patti J.M., Jonsson H., Guss B., Switalski L.M., Wiberg K., Lindberg M., and Höök M. (1992). Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. Journal of Biological Chemistry 267, 4766–4772. 10.1016/s0021-9258(18)42898-0. [DOI] [PubMed] [Google Scholar]
  • 20.Elasri M.O., Thomas J.R., Skinner R.A., Blevins J.S., Beenken K.E., Nelson C.L., and Smelter M.S. (2002). Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone 30, 275–280. 10.1016/S8756-3282(01)00632-9. [DOI] [PubMed] [Google Scholar]
  • 21.Rhem M.N., Lech E.M., Patti J.M., McDevitt D., Höök M., Jones D.B., and Wilhelmus K.R. (2000). The Collagen-Binding Adhesin Is a Virulence Factor in Staphylococcus aureus Keratitis. Infect Immun 68, 3776. 10.1128/IAI.68.6.3776-3779.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kang M., Ko Y.P., Liang X., Ross C.L., Liu Q., Murray B.E., and Höök M. (2013). Collagen-binding Microbial Surface Components Recognizing Adhesive Matrix Molecule (MSCRAMM) of Gram-positive Bacteria Inhibit Complement Activation via the Classical Pathway. J Biol Chem 288, 20520. 10.1074/JBC.M113.454462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Giang J., Seelen M.A.J., van Doorn M.B.A., Rissmann R., Prens E.P., and Damman J. (2018). Complement Activation in Inflammatory Skin Diseases. Front Immunol 9, 639. 10.3389/fimmu.2018.00639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pouw R.B., and Ricklin D. (2021). Tipping the balance: intricate roles of the complement system in disease and therapy. Seminars in Immunopathology 2021 43:6 43, 757–771. 10.1007/S00281-021-00892-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fuchs T.A., Abed U., Goosmann C., Hurwitz R., Schulze I., Wahn V., Weinrauch Y., Brinkmann V., and Zychlinsky A. (2007). Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176, 231–241. 10.1083/jcb.200606027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., and Zychlinsky A. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532–1535. 10.1126/science.1092385. [DOI] [PubMed] [Google Scholar]
  • 27.Kandhwal M., Behl T., Singh S., Sharma N., Arora S., Bhatia S., Al-Harrasi A., Sachdeva M., and Bungau S. (2022). Role of matrix metalloproteinase in wound healing. Am J Transl Res 14, 4391. 10.31838/ijpr/2020.SP2.087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Taylor J.L., Hattle J.M., Dreitz S.A., Troudt J.L.M., Izzo L.S., Basaraba R.J., Orme I.M., Matrisian L.M., and Izzo A.A. (2006). Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 74, 6135–6144. 10.1128/IAI.02048-05/SUPPL_FILE/AI_TB_32ZYMOG.DOC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Malik M., Bakshi C.S., McCabe K., Catlett S. V., Shah A., Singh R., Jackson P.L., Gaggar A., Metzger D.W., Melendez J.A., et al. (2007). Matrix Metalloproteinase 9 Activity Enhances Host Susceptibility to Pulmonary Infection with Type A and B Strains of Francisella tularensis. The Journal of Immunology 178, 1013–1020. 10.4049/JIMMUNOL.178.2.1013. [DOI] [PubMed] [Google Scholar]
  • 30.Elkington P.T.G., O’Kane C.M., and Friedland J.S. (2005). The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142, 12. 10.1111/J.1365-2249.2005.02840.X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pidwill G.R., Gibson J.F., Cole J., Renshaw S.A., and Foster S.J. (2021). The Role of Macrophages in Staphylococcus aureus Infection. Front Immunol 11, 620339. 10.3389/FIMMU.2020.620339/BIBTEX. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Houghton A.M.G., Hartzell W.O., Robbins C.S., Gomis-Rüth F.X., and Shapiro S.D. (2009). Macrophage elastase kills bacteria within murine macrophages. Nature 460, 637. 10.1038/NATURE08181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Stsiapanava A., Olsson U., Wan M., Kleinschmidt T., Rutishauser D., Zubarev R.A., Samuelsson B., Rinaldo-Matthis A., and Haeggström J.Z. (2014). Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor. Proc Natl Acad Sci U S A 111, 4227–4232. 10.1073/PNAS.1402136111/SUPPL_FILE/PNAS.201402136SI.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Brown M.M., Kwiecinski J.M., Cruz L.M., Shahbandi A., Todd D.A., Cech N.B., and Horswill A.R. (2020). Novel Peptide from Commensal Staphylococcus simulans Blocks Methicillin-Resistant Staphylococcus aureus Quorum Sensing and Protects Host Skin from Damage. Antimicrob Agents Chemother 64. 10.1128/AAC.00172-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kwiecinski Id J.M., Crosby H.A., Valotteau C., Id J.A.H., Nayak M.K., Chauhanid A.K., Schmidt E.P., Dufrêne Y.F., and Horswill A.R. (2019). Staphylococcus aureus adhesion in endovascular infections is controlled by the ArlRS-MgrA signaling cascade. 10.1371/journal.ppat.1007800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Pelzek A.J., Shopsin B., Radke E.E., Tam K., Ueberheide B.M., Fenyö D., Brown S.M., Li Q., Rubin A., Fulmer Y., et al. (2018). Human memory B cells targeting Staphylococcus aureus exotoxins are prevalent with skin and soft tissue infection. mBio 9. 10.1128/MBIO.02125-17/ASSET/882A0284-3A6D-4893-91C3-9005C71C09A9/ASSETS/GRAPHIC/MBO0021837730005.JPEG. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Phillips M., Rosenberg A., Shopsin B., Cuff G., Skeete F., Foti A., Kraemer K., Inglima K., Press R., and Bosco J. (2014). Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol 35, 826–832. 10.1086/676872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Foster C.E., Kok M., Flores A.R., Minard C.G., Luna R.A., Lamberth L.B., Kaplan S.L., and Hulten K.G. (2020). Adhesin genes and biofilm formation among pediatric Staphylococcus aureus isolates from implant-associated infections. PLoS One 15. 10.1371/JOURNAL.PONE.0235115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Brandt S.L., Putnam N.E., Cassat J.E., and Serezani C.H. (2018). Innate Immunity to Staphylococcus aureus : Evolving Paradigms in Soft Tissue and Invasive Infections. The Journal of Immunology 200, 3871–3880. 10.4049/JIMMUNOL.1701574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Berube B.J., and Wardenburg J.B. (2013). Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue. Toxins (Basel) 5, 1140. 10.3390/TOXINS5061140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ortines R. V., Liu H., Cheng L.I., Cohen T.S., Lawlor H., Gami A., Wang Y., Dillen C.A., Archer N.K., Miller R.J., et al. (2018). Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice. Antimicrob Agents Chemother 62. 10.1128/AAC.02288-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yu Y.R.A., O’Koren E.G., Hotten D.F., Kan M.J., Kopin D., Nelson E.R., Que L., and Gunn M.D. (2016). A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues. PLoS One 11, e0150606. 10.1371/JOURNAL.PONE.0150606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chen X., Schneewind O., and Missiakas D. (2022). Engineered human antibodies for the opsonization and killing of Staphylococcus aureus. Proc Natl Acad Sci U S A 119, e2114478119. 10.1073/PNAS.2114478119/SUPPL_FILE/PNAS.2114478119.SAPP.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ricklin D., Hajishengallis G., Yang K., and Lambris J.D. (2010). Complement: a key system for immune surveillance and homeostasis. Nature Immunology 2010 11:9 11, 785–797. 10.1038/ni.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Thammavongsa V., Missiakas D.M., and Schneewind O. (2013). Staphylococcus aureus Degrades Neutrophil Extracellular Traps to Promote Immune Cell Death. Science (1979) 342, 863–866. 10.1126/science.1242255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Nauseef W.M. (2007). Isolation of Human Neutrophils From Venous Blood. In Methods in molecular biology (Clifton, N.J.), pp. 15–20. 10.1007/978-1-59745-467-4_2. [DOI] [PubMed] [Google Scholar]
  • 47.Bhattacharya M., Berends E.T.M., Zheng X., Hill P.J., Chan R., Torres V.J., and Wozniak D.J. (2020). Leukocidins and the nuclease Nuc prevent neutrophil mediated killing of Staphylococcus aureus biofilms. Infect Immun. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Krishnaswamy V.R., Mintz D., and Sagi I. (2017). Matrix metalloproteinases: The sculptors of chronic cutaneous wounds. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864, 2220–2227. 10.1016/J.BBAMCR.2017.08.003. [DOI] [PubMed] [Google Scholar]
  • 49.Chou R.C., Kim N.D., Sadik C.D., Seung E., Lan Y., Byrne M.H., Haribabu B., Iwakura Y., and Luster A.D. (2010). Lipid-Cytokine-Chemokine Cascade Drives Neutrophil Recruitment in a Murine Model of Inflammatory Arthritis. Immunity 33, 266. 10.1016/J.IMMUNI.2010.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rhem M.N., Lech E.M., Patti J.M., McDevitt D., Höök M., Jones D.B., and Wilhelmus K.R. (2000). The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis. Infect Immun 68, 3776–3779. 10.1128/IAI.68.6.3776-3779.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Hienz S.A., Schennings T., Heimdahl A., and Flock J.I. (1996). Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 174, 83–88. [DOI] [PubMed] [Google Scholar]
  • 52.Pelzek A.J., Shopsin B., Radke E.E., Tam K., Ueberheide B.M., Fenyö D., Brown S.M., Li Q., Rubin A., Fulmer Y., et al. (2018). Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection. mBio 9. 10.1128/MBIO.02125-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ray G.T., Suaya J.A., and Baxter R. (2013). Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis 13, 252. 10.1186/1471-2334-13-252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Cho S.H., Strickland I., Tomkinson A., Fehringer A.P., Gelfand E.W., and Leung D.Y.M. (2001). Preferential Binding of Staphylococcus aureus to Skin Sites of Th2-Mediated Inflammation in a Murine Model. Journal of Investigative Dermatology 116, 658–663. 10.1046/J.0022-202X.2001.01331.X. [DOI] [PubMed] [Google Scholar]
  • 55.Cho S.H., Strickland I., Boguniewicz M., and Leung D.Y.M. (2001). Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 108, 269–274. 10.1067/MAI.2001.117455. [DOI] [PubMed] [Google Scholar]
  • 56.Del Giudice P., Bes M., Hubiche T., Blanc V., Roudière L., Lina G., Vandenesch F., and Etienne J. (2011). Panton-valentine leukocidin-positive Staphylococcus aureus strains are associated with follicular skin infections. Dermatology 222, 167–170. 10.1159/000324044. [DOI] [PubMed] [Google Scholar]
  • 57.Friesen J., Neuber R., Fuhrmann J., Kietzmann H., Wenzel T., Schaumburg F., Müller M., and Ignatius R. (2020). Panton-Valentine leukocidin–positive Staphylococcus aureus in skin and soft tissue infections from primary care patients. Clinical Microbiology and Infection 26, 1416.e1-1416.e4. 10.1016/J.CMI.2020.06.029. [DOI] [PubMed] [Google Scholar]
  • 58.Jin Y., Zhou W., Ge Q., Shen P., and Xiao Y. (2024). Epidemiology and clinical features of Skin and Soft Tissue Infections Caused by PVL-Positive and PVL-Negative Methicillin-Resistant Staphylococcus aureus Isolates in inpatients in China: a single-center retrospective 7-year study. Emerg Microbes Infect 13. 10.1080/22221751.2024.2316809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Vandendriessche S., Cambier S., Proost P., and Marques P.E. (2021). Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis. Front Cell Dev Biol 9, 624025. 10.3389/FCELL.2021.624025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Boero E., Gorham R.D., Francis E.A., Brand J., Teng L.H., Doorduijn D.J., Ruyken M., Muts R.M., Lehmann C., Verschoor A., et al. (2023). Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1. Scientific Reports 2023 13:1 13, 1–17. 10.1038/s41598-022-27279-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Spaan A.N., Henry T., van Rooijen W.J.M., Perret M., Badiou C., Aerts P.C., Kemmink J., de Haas C.J.C., van Kessel K.P.M., Vandenesch F., et al. (2013). The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors. Cell Host Microbe 13, 584–594. 10.1016/j.chom.2013.04.006. [DOI] [PubMed] [Google Scholar]
  • 62.Spaan A.N., van Strijp J.A.G., and Torres V.J. (2017). Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors. Nat Rev Microbiol 15, 435–447. 10.1038/nrmicro.2017.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Yoong P., and Torres V.J. (2013). The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Curr Opin Microbiol 16, 63–69. 10.1016/j.mib.2013.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.DuMont A.L., Yoong P., Surewaard B.G.J., Benson M.A., Nijland R., van Strijp J.A.G., and Torres V.J. (2013). Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect Immun 81, 1830–1841. 10.1128/IAI.00095-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.DuMont A.L., Yoong P., Day C.J., Alonzo F., McDonald W.H., Jennings M.P., and Torres V.J. (2013). Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci U S A 110, 10794–10799. 10.1073/pnas.1305121110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Forde A.J., Kolter J., Zwicky P., Baasch S., Lohrmann F., Eckert M., Gres V., Lagies S., Gorka O., Rambold A.S., et al. (2023). Metabolic rewiring tunes dermal macrophages in staphylococcal skin infection. Sci Immunol 8. 10.1126/SCIIMMUNOL.ADG3517/SUPPL_FILE/SCIIMMUNOL.ADG3517_MDAR_REPRODUCIBILITY_CHECKLIST.PDF. [DOI] [PubMed] [Google Scholar]
  • 67.Abtin A., Jain R., Mitchell A.J., Roediger B., Brzoska A.J., Tikoo S., Cheng Q., Ng L.G., Cavanagh L.L., Von Andrian U.H., et al. (2013). Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nature Immunology 2013 15:1 15, 45–53. 10.1038/ni.2769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Ruiz S.S., Tenner A.J., Ruiz S., Henschen-Edman A.H., Nagase H., and Tenner A.J. (1999). Digestion of C1q collagen-like domain with MMPs-1,−2,−3, and-9 further defines the sequence involved in the stimulation of neutrophil superoxide production. Article in Journal of Leukocyte Biology 66, 416–422. 10.1002/jlb.66.3.416. [DOI] [PubMed] [Google Scholar]
  • 69.Sinha M., Sen C.K., Singh K., Das A., Ghatak S., Rhea B., Blackstone B., Powell H.M., Khanna S., and Roy S. (2018). Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue. Nat Commun 9. 10.1038/S41467-018-03208-W. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Urso A., Monk I.R., Cheng Y.T., Predella C., Wong Fok Lung T., Theiller E.M., Boylan J., Perelman S., Baskota S.U., Moustafa A.M., et al. (2024). Staphylococcus aureus adapts to exploit collagen-derived proline during chronic infection. Nature Microbiology 2024, 1–16. 10.1038/s41564-024-01769-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Gordon S., Plüddemann A., and Martinez Estrada F. (2014). Macrophage heterogeneity in tissues: Phenotypic diversity and functions. Immunol Rev 262, 36–55. 10.1111/IMR.12223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Jopling C., Boue S., and Belmonte J.C.I. (2011). Dedifferentiation, transdifferentiation and reprogramming: Three routes to regeneration. Nat Rev Mol Cell Biol 12, 79–89. 10.1038/NRM3043. [DOI] [PubMed] [Google Scholar]
  • 73.Bidula S., Sexton D.W., and Schelenz S. (2019). Ficolins and the Recognition of Pathogenic Microorganisms: An Overview of the Innate Immune Response and Contribution of Single Nucleotide Polymorphisms. J Immunol Res 2019. 10.1155/2019/3205072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Lacroix M., Tessier A., Dumestre-Pérard C., Vadon-Le Goff S., Gout E., Bruckner-Tuderman L., Kiritsi D., Nyström A., Ricard-Blum S., Moali C., et al. (2017). Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases. Scientific Reports 2017 7:1 7, 1–13. 10.1038/s41598-017-17318-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Rosbjerg A., Plchová T.A., Bayarri-Olmos R., Holm B.E., Pedersen I.S., Skjoedt M.-O., and Garred P. (2024). C1q/MASP Complexes—Hybrid Complexes of Classical and Lectin Pathway Proteins Are Found in the Circulation. The Journal of Immunology 213, 998–1007. 10.4049/JIMMUNOL.2400185. [DOI] [PubMed] [Google Scholar]
  • 76.Singh D., Rai V., and Agrawal D.K. (2023). Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration. Cardiol Cardiovasc Med 7, 5. 10.26502/FCCM.92920302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Tong S.Y.C., Davis J.S., Eichenberger E., Holland T.L., and Fowler V.G. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28, 603–661. 10.1128/CMR.00134-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Thomer L., Schneewind O., and Missiakas D. (2016). Pathogenesis of Staphylococcus aureus Bloodstream Infections. Annual Review of Pathology: Mechanisms of Disease 11, 343–364. 10.1146/annurev-pathol-012615-044351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Kwiecinski J., Jacobsson G., Karlsson M., Zhu X., Wang W., Bremell T., Josefsson E., and Jin T. (2013). Staphylokinase promotes the establishment of Staphylococcus aureus skin infections while decreasing disease severity. J Infect Dis 208, 990–999. 10.1093/INFDIS/JIT288. [DOI] [PubMed] [Google Scholar]
  • 80.Bhattacharya M., Berends E.T.M., Chan R., Schwab E., Roy S., Sen C.K., Torres V.J., and Wozniak D.J. (2018). Staphylococcus aureus biofilms release leukocidins to elicit extracellular trap formation and evade neutrophil-mediated killing. Proceedings of the National Academy of Sciences. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Vandenesch F., Lina G., and Henry T. (2012). Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol 2, 12. 10.3389/fcimb.2012.00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Thammavongsa V., Kim H.K., Missiakas D., and Schneewind O. (2015). Staphylococcal manipulation of host immune responses. Nat Rev Microbiol 13, 529–543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Kavanaugh J.S., Flack C.E., Lister J., Ricker E.B., Ibberson C.B., Jenul C., Moormeier D.E., Delmain E.A., Bayles K.W., and Horswill A.R. (2019). Identification of extracellular DNA-binding proteins in the biofilm matrix. mBio 10. 10.1128/MBIO.01137-19/SUPPL_FILE/MBIO.01137-19-ST002.DOCX. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Chen S., Zhou Y., Chen Y., and Gu J. (2018). fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890. 10.1093/BIOINFORMATICS/BTY560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Low A.J., Koziol A.G., Manninger P.A., Blais B., and Carrillo C.D. (2019). ConFindr: rapid detection of intraspecies and cross-species contamination in bacterial whole-genome sequence data. PeerJ 7. 10.7717/PEERJ.6995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Wick R.R., Judd L.M., Gorrie C.L., and Holt K.E. (2017). Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13. 10.1371/JOURNAL.PCBI.1005595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Chaumeil P.A., Mussig A.J., Hugenholtz P., and Parks D.H. (2020). GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database. Bioinformatics 36, 1925–1927. 10.1093/BIOINFORMATICS/BTZ848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. (1990). Basic local alignment search tool. J Mol Biol 215, 403–410. 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  • 89.Kanehisa M., and Goto S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27–30. 10.1093/NAR/28.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.docx (3.5MB, docx)

Data Availability Statement

Data reported in this manuscript will be made available by the lead contact upon request.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES